Completed PHASE1/PHASE2 INTERVENTIONAL 3-arm NCT01916239

Pomegranate Extract Supplementation in Colorectal Cancer Patients (POMEcolon)

Phase I-II Study of Pomegranate Extract Formulations in Colorectal Cancer Patients: Metabolic and Gene Expression Profiling in Tumoral and Normal Colon Tissues

Sponsor: Hospital Universitario Reina Sofia de Cordoba

Conditions Colorectal Cancer

Interventions Pomegranate extract formulation-1 Pomegranate extract formulation-2 Standard pomegranate extract formulation

Updated 6 times since 2017 Last updated: Apr 13, 2015 Started: Jun 30, 2012 Primary completion: Feb 28, 2015 Completion: Apr 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Colorectal Cancer, this trial is completed. The trial is conducted by Hospital Universitario Reina Sofia de Cordoba and has accumulated 6 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Apr 2018 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Universitario Reina Sofia de Cordoba
National Research Council, Spain

Data source: National Research Council, Spain

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Murcia, Spain